Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Levetiracetam (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 20 Aug 2024 Status changed from active, no longer recruiting to completed.
- 19 Oct 2023 Planned End Date changed from 30 Sep 2023 to 30 Jun 2024.
- 19 Oct 2023 Planned primary completion date changed from 30 Sep 2023 to 30 Jun 2024.